This article has been updated with additional information about coverage of NIPT.
NEW YORK – Natera has found that the performance of its Panorama noninvasive prenatal screening (NIPS) test has stayed consistently high over several years, even as testing has shifted to a younger age group with lower risk for fetal aneuploidies. In addition, the firm is nearing completion of a prospective clinical study that it says will further bolster these results, not only for common fetal trisomies but also for some microdeletions.